Treatment of intrabony defects
Phase 3
- Conditions
- Health Condition 1: K053- Chronic periodontitis
- Registration Number
- CTRI/2023/08/057143
- Lead Sponsor
- Raaja Sreepathy CS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Apparently healthy individuals.
2. Presence of Intrabony defect (IBD) depth =3 mm and interproximal probing depth (PD) =5 mm after phase I therapy.
Exclusion Criteria
1. HISTORY OF :
Aggressive Periodontitis. Smoking and tobacco use. Systemic conditions known to affect the periodontal status. Medications known to affect the gingival condition
2. Pregnant or lactating women.
3. Hematological disorders and insufficient platelet count after re-evaluation of Phase I therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical outcome assessment. <br/ ><br>1. PD- Probing Depth <br/ ><br>2. RAL- Relative Attachment Level <br/ ><br>3. GML – Gingival Marginal Level <br/ ><br>Timepoint: Baseline, 3 months and 6 months
- Secondary Outcome Measures
Name Time Method radiographic parameters <br/ ><br>1. Level of alveolar crest <br/ ><br>2. Base of Intra Bony Defect <br/ ><br>3. Defect fillTimepoint: All parameters are assessed at 0,3 & 6 months interval.